Throughout these experiments, sirtuin inhibitors and HDAC inhibitors were found to have partial cytotoxic activity in leukemia cells when used as single agents (with specific cell deaths that were typically <50%) (Figure 1, S1, S2, S3, and Tables S1, S2, S3, S4). Here, HDAC9 is linked to leukemia.